| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.94▼ | 8.87▲ | 8.92▼ | 9.79▼ | 8.20▲ |
| MA10 | 8.87▲ | 8.97▼ | 9.39▼ | 9.03▼ | 7.38▲ |
| MA20 | 8.85▲ | 9.38▼ | 9.73▼ | 8.43▲ | 8.20▲ |
| MA50 | 8.92▼ | 9.69▼ | 9.49▼ | 7.37▲ | 9.80▼ |
| MA100 | 9.27▼ | 9.31▼ | 8.71▲ | 8.24▲ | 8.41▲ |
| MA200 | 9.68▼ | 8.65▲ | 7.84▲ | 10.00▼ | 5.08▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.026▲ | -0.046▼ | -0.165▼ | 0.153▲ | 0.246▲ |
| RSI | 51.399▲ | 40.246▼ | 41.260▼ | 55.249▲ | 51.631▲ |
| STOCH | 82.660▲ | 27.689 | 27.434 | 79.611 | 56.113 |
| WILL %R | -35.938 | -75.485▼ | -77.252▼ | -49.280 | -32.448 |
| CCI | 103.586▲ | -42.928 | -74.937 | 18.891 | 93.359 |
|
Saturday, May 09, 2026 08:05 PM
Ginkgo Bioworks (NYSE:DNA) said it is sharpening its 2026 focus on autonomous laboratories after completing the divestiture of its biosecurity business and reporting lower year-over-year cash burn in ...
|
|
Friday, May 08, 2026 09:22 AM
Ginkgo Bioworks (DNA) shares plunge on FY26 cash burn guidance and Q1 results: revenue down 50% and cash burn trends.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/05/26 | 8.65 | 9.5435 | 8.35 | 8.93 | 2,086,789 |
| 07/05/26 | 10.00 | 10.64 | 9.7258 | 10.32 | 2,036,555 |
| 06/05/26 | 9.62 | 10.34 | 9.15 | 10.08 | 1,907,195 |
| 05/05/26 | 10.13 | 10.21 | 9.51 | 9.71 | 1,250,627 |
| 04/05/26 | 9.54 | 10.5988 | 9.3456 | 9.91 | 2,170,553 |
| 01/05/26 | 8.6847 | 9.77 | 8.40 | 9.70 | 1,971,268 |
| 30/04/26 | 7.53 | 8.61 | 7.515 | 8.46 | 1,502,698 |
| 29/04/26 | 7.75 | 7.765 | 7.17 | 7.50 | 1,264,866 |
| 28/04/26 | 7.58 | 7.885 | 7.57 | 7.85 | 536,357 |
| 27/04/26 | 7.79 | 8.05 | 7.535 | 7.82 | 809,904 |
|
|
||||
|
|
||||
|
|